AFP-ALPHA FETO PROTEIN

Alpha-fetoprotein (AFP) serves as a critical tumor marker aiding in the detection and diagnosis of specific cancers and liver diseases. In pregnancy, AFP blood testing is utilized to assess the potential risk of congenital disabilities or genetic disorders in the developing fetus. While AFP testing, often paired with ultrasonography, is instrumental in screening high-risk individuals for hepatocellular carcinoma, it’s not typically employed as a standalone diagnostic tool. Instead, it is part of a comprehensive assessment that includes various tests to provide a comprehensive view of the patient’s health status. Elevated AFP levels can be indicative of underlying health concerns, yet it’s important to note that low levels of AFP are naturally present in most individuals. Despite elevated levels often correlating with liver disease, certain cancers, or pregnancy, it’s crucial to interpret results in conjunction with other clinical information for accurate diagnosis and proper medical management. This overview aims to provide essential insights into AFP tumor marker testing, covering its uses, normal ranges, and the significance of test results in clinical contexts.